PANDA
AI-powered medical imaging analysis platform
Software · OtherCompany source
Company profile
About IB Lab
IB Lab PANDA is a healthcare AI product developed by ImageBiopsy Lab (IB Lab) that operates in the medical imaging and radiology space. The product name PANDA suggests a specialized AI solution for radiological analysis, though specific clinical applications and technical capabilities require further investigation. ImageBiopsy Lab appears to focus on developing AI-powered diagnostic tools for medical imaging interpretation. As a radiology-focused solution, PANDA likely serves healthcare providers, radiologists, and medical imaging facilities seeking to enhance diagnostic accuracy and workflow efficiency through artificial intelligence. The company operates in the growing field of AI-assisted medical imaging, where machine learning algorithms are increasingly used to support clinical decision-making and improve patient outcomes.
Company description IB Lab official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at IB Lab?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Health Systems
- Providers
Deployment & integration
Other deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
AI-supported opportunistic detection of vertebral fractures on routine CT scans: Diagnostic performance and clinical relevance.Bone · Feb 1, 2026
Are artificial intelligence generated lower extremity radiographic measurements accurate in a cohort with implants?Skeletal radiology · Oct 1, 2025
Breaking the silence: AI's contribution to detecting vertebral fractures in opportunistic CT scans in the elderly-a validation study.Archives of osteoporosis · Mar 25, 2025
Reliability assessment of leg length and angular alignment on manual reads versus artificial intelligence-generated lower extremity radiographic measurements.Clinical imaging · Sep 1, 2024
Deep learning generated lower extremity radiographic measurements are adequate for quick assessment of knee angular alignment and leg length determination.Skeletal radiology · May 1, 2024
Mussismilia braziliensis White Plague Disease Is Characterized by an Affected Coral Immune System and Dysbiosis.Microbial ecology · Apr 1, 2021
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
IB Lab LAMAK223646 · 510k · Jun 16, 2023
KOALAK192109 · 510k · Nov 5, 2019
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from IB Lab
Recent articles published on IB Lab's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.